Max Hoffer
Impact in
- Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Synthesis and Characterization of Heterocyclic Compounds 4
- Synthesis and biological activity 2
- Quinazolinone synthesis and applications 1
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Emanuel Grunberg (4 shared papers)Jack J. Fox (4 shared papers)R. U. Lemieux (1 shared paper)Naishun C. Yung (2 shared papers)Robert Duschinsky (2 shared papers)A. BROSSI (2 shared papers)Iris Wempen (1 shared paper)Voldemar Toome (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (6 papers)Journal of the American Chemical Society (2 papers)Annual reports in medicinal chemistry (2 papers)Canadian Journal of Chemistry (1 paper)Chemische Berichte (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Max Hoffer
14 papers receiving 559 citations
Peers
Comparison fields: 5 of 63
- Organic Chemistry 344
- Infectious Diseases 147
- Pharmaceutical Science 45
- Molecular Biology 407
- Physiology 22
Countries citing papers authored by Max Hoffer
This map shows the geographic impact of Max Hoffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Hoffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Hoffer more than expected).
Fields of papers citing papers by Max Hoffer
This network shows the impact of papers produced by Max Hoffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Hoffer. The network helps show where Max Hoffer may publish in the future.
Co-authors
The 18 scholars most cited alongside Max Hoffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1960 | 324 | |
| 2 | 1959 | 61 | |
| 3 | 1974 | 52 | |
| 4 | 1961 | 50 | |
| 5 | 1961 | 40 | |
| 6 | 1967 | 36 | |
| 7 | 1966 | 27 | |
| 8 | 1971 | 13 | |
| 9 | 1971 | 10 | |
| 10 | Antihistomonal activity of 1,2-disubstituted 5-nitroimidazoles. | 1968 | 9 |
| 11 | 1971 | 9 | |
| 12 | 1966 | 7 | |
| 13 | 1972 | 2 | |
| 14 | 1973 | 1 |
About Max Hoffer
Max Hoffer is a scholar working on Organic Chemistry, Toxicology, Molecular Biology, Parasitology and Small Animals, having authored 14 papers that have together received 641 indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Synthesis and biological activity (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Muon and positron interactions and applications (1 paper), Molecular spectroscopy and chirality (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Organic Chemistry (344 citations), Infectious Diseases (147 citations), Pharmaceutical Science (45 citations), Molecular Biology (407 citations) and Physiology (22 citations). Max Hoffer has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Emanuel Grunberg, Jack J. Fox, R. U. Lemieux, Naishun C. Yung, Robert Duschinsky, A. BROSSI, Iris Wempen, Voldemar Toome, Arnold R. Brossi and Thomas F. Gabriel. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of the American Chemical Society, Annual reports in medicinal chemistry, Canadian Journal of Chemistry and Chemische Berichte.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.